Barrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on Merit Medical Systems (MMSI) and raised the price target from $96 to $98.
February 29, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems' Outperform rating is maintained by Barrington Research, with a price target increase from $96 to $98.
The maintenance of an Outperform rating combined with an increased price target typically signals analyst confidence in the company's future performance, potentially leading to positive investor sentiment and a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100